Sofosbuvir
索非布韦 | Sofosbuvir | 1190307-88-0 | Endlwini |
SFBM | 1256490-31-9 | Endlwini | |
SFB-8 | 874638-80-9 | Endlwini | |
SFB-10 | 817204-32-3 | Endlwini | |
SFBA-1 | 863329-66-2 | Endlwini | |
SFBMA | 1334513-02-8 | Endlwini |
Igama leGeneric: sofosbuvir (soe FOS bue vir)
Amagama eBrand: Sovaldi
I-Sofosbuvir liyeza le-antiviral elisetyenziselwa ukunyanga i-hepatitis C engapheliyo kubantu abadala kunye nabantwana ubuncinane abaneminyaka emi-3 ubudala kunye ne-HCV RNA replication inhibitor ene-EC50 yama-92 nM.
I-Sofosbuvir kufuneka inikwe zidityaniswe namanye amayeza e-antiviral (ngokuqhelekileyo i-ribavirin ene-peginterferon alfa okanye ngaphandle kwayo).ISofosbuvir akufuneki isetyenziswe yodwa.
I-Sofosbuvir iphatha i-genotypes ethile ye-hepatitis C, kwaye kuphela kubantu abathile.Sebenzisa kuphela amayeza amiselweyo kuwe.Musa ukwabelana ngamayeza akho nabanye abantu.
I-Sofosbuvir ngamanye amaxesha isetyenziswa kubantu abane-HIV, okanye abantu abanomhlaza wesibindi nabaza kwenzelwa uqhaqho-fakelo lwesibindi.Eli yeza ayilonyango lwe-HIV okanye uGawulayo.
Ugcino
Umgubo | -20°C | Iminyaka emi-3 |
4°C | iminyaka eyi-2 | |
Kwi-solvent | -80°C | Iinyanga ezi-6 |
-20°C | Inyanga eyi-1 |
Ubume beMichiza
Isindululo18Iiprojekthi zoVavanyo loBulunga ezivunyiweyo4, kwaye6iiprojekthi ziphantsi kolwamkelo.
Inkqubo yolawulo lomgangatho wehlabathi ephucukileyo ibeke isiseko esiluqilima sokuthengisa.
Ukongamela umgangatho kutyhutyha umjikelo wobomi bemveliso ukuqinisekisa umgangatho kunye nesiphumo sonyango.
Iqela leMicimbi yoLawulo lobuGcisa lixhasa iimfuno zomgangatho ngexesha lesicelo nokubhaliswa.